{
    "type": "ETF",
    "ucits": true,
    "fund_name": "AMUNDI PRIME EMERGING MARKETS - UCITS ETF DR",
    "investment_objective": "Track the performance of Solactive GBS Emerging Markets Large & Mid Cap USD Index with minimized tracking error",
    "primary_asset_class": "Equity",
    "geographic_focus": "Emerging Markets (26 countries including China, Taiwan, India, Korea, Brazil, etc.)",
    "replication_method": "physical",
    "swaps": false,
    "derivatives": false,
    "leverage": false,
    "inverse": false,
    "complex_factors": [],
    "classification": "non-complex",
    "supporting_data": "The ETF is a UCITS fund physically replicating the Solactive GBS Emerging Markets Large & Mid Cap USD Index by direct investment in underlying securities. The KIID and PRIIPs KID explicitly state the use of direct replication with only limited derivative use for operational purposes such as managing inflows/outflows or better exposure to index constituents, not as an inherent part of the investment strategy. There is no mention of synthetic replication, swap agreements, total return swaps, or counterparty risk related to derivatives. The fund does not employ leverage, inverse or amplified exposure. The risk profile is moderate (4/7), consistent with equity exposure to emerging markets, without complex structured features or capital protection mechanisms. Costs are straightforward with a low ongoing charge (0.10%) and no performance fees. The factsheet confirms physical replication, no use of swaps, and a transparent, liquid portfolio of large and mid-cap emerging market equities. No complexity flags such as contingent convertible bonds, structured products, or significant derivative exposure are present. The PRIIPs KID does not include any comprehension warnings or complexity disclaimers. Overall, the ETF exhibits a clear, linear relationship to the underlying index performance and is suitable for retail investors with basic investment knowledge.",
    "risk_level_assessment": "The fund's risk rating of 4 out of 7 reflects typical equity market risk in emerging markets but does not indicate complexity. The absence of leverage, synthetic replication, or complex derivatives aligns with a non-complex classification under MiFID II."
}